H.C. Wainwright analyst Patrick Trucchio raised the firm’s price target on Arrowhead (ARWR) to $80 from $60 and keeps a Buy rating on the ...
Shares of Janux Therapeutics Inc. surged over 54% on Tuesday afternoon, reaching levels not seen since May and breaking a ...
H.C. Wainwright analyst Mike Colonnese says CleanSpark (CLSK) reported solid fiscal Q4 results and reiterated its prior calendar year-end 2024 ...
Purple Biotech shares are trading lower by 28% during Tuesday's session. The company announced a $2.8 million offering.
On Friday, Energy Fuels Inc (UUUU) stock saw a modest uptick, ending the day at $7.29 which represents a slight increase of $0.49 or 7.21% from the prior close of $6.8. The stock opened at $7.1 and ...
Viracta Therapeutics Inc (VIRX) stock saw a modest uptick, ending the day at $0.16 which represents a slight increase of $0.02 or 14.29% from the prior close of $0.14. The stock opened at $0.15 and ...
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares ...
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares following the Q3 report. The business stalled until new funding ...
H.C. Wainwright raised the firm’s price target on BridgeBio (BBIO) to $49 from $43 and keeps a Buy rating on the shares. Acoramidis received regulatory approval with the label underscoring ...
H.C. Wainwright & Co. analyst Mike Colonnese sees clear skies ahead for crypto industry as a “major regulatory overhang” has been lifted. Bitcoin soars to all-time highs following Trump’s ...
Phunware (NASDAQ:PHUN) shares retreated 11% in Tuesday late morning trading after H.C. Wainwright & Co. downgraded the application software company to Neutral from Buy, as analyst Scott Buck ...
Ardelyx (NASDAQ:ARDX) shares were down over 5% after H.C. Wainwright downgraded the rating for the biopharmaceutical firm, saying that it anticipates a substantial drop in the company's kidney ...